SearchDictionaryMobileLogin

Surgical Portacaval Shunt (Portacaval Anastomosis)

928  relevant articles (31 outcomes, 68 trials/studies) found for this Therapy

Description: Surgical portasystemic shunt between the portal vein and inferior vena cava.

Also Known As:
Portacaval Anastomosis; Portacaval Shunt, Surgical; Portacaval Shunt; Shunt, Surgical Portacaval; Anastomoses, Portacaval; Anastomosis, Portacaval; Fistula, Eck; Portacaval Anastomoses; Portacaval Shunts; Portacaval Shunts, Surgical; Shunt, Portacaval; Shunts, Portacaval; Shunts, Surgical Portacaval; Surgical Portacaval Shunts; Eck Fistula

Relationship Network

Therapy Context: Research Results

Experts

1. Rodrigo, Regina: 2 articles (08/2007 - 02/2005)
2. Felipo, Vicente: 2 articles (08/2007 - 02/2005)
3. Blei, A T: 2 articles (08/2001 - 07/2001)
4. Theodoraki, K: 1 article (01/2008)
5. Skalkidis, I: 1 article (01/2008)
6. Andreadou, I: 1 article (01/2008)
7. Tzavara, K: 1 article (01/2008)
8. Dimopoulou, K: 1 article (01/2008)
9. Sidiropoulou, T: 1 article (01/2008)
10. Hatzoudi, E: 1 article (01/2008)

Related Diseases

1. Hemorrhage
2. Ascites
3. Varicose Veins (Varicose Vein)
4. Portal Hypertension
5. Fibrosis (Cirrhosis)
01/01/1989 - "These studies suggest that the delay in clearance of administered particles in portacaval shunt and portacaval transposition rats is related to the portal diversion rather than to altered blood flow and thus the finding is of relevance in patients with cirrhosis who also have significant portacaval shunting."
06/01/1976 - "To study resectability and regeneration of cirrhotic liver, hemodynamic changes following partial hepatectomy were observed in dogs with presinusoidal block caused by ligation of the portal vein or with postsinusoidal block caused by ligation of the hepatic veins after portacaval anastomosis, since cirrhosis of the liver in man is mainly of postsinusoidal block occasionally accompanied by presinusoidal block"
11/03/1967 - "Long-term results of termino-lateral truncal portacaval anastomosis for cirrhosis (study of 100 patients operated between 1959 and 1964)]"
01/01/2007 - "Four patients (cirrhosis 3, portal vein block 1) continued to bleed in the postoperative period following gastro-esophageal devascularization (3) or portacaval shunt (1)"
09/01/2000 - "METHODS: From 1972 to 1999, the authors conducted prospective studies of the treatment of 60 patients with BCS who were divided into three groups: the first had occlusion confined to the hepatic veins treated by direct side-to-side portacaval shunt (SSPCS); the second had occlusion involving the inferior vena cava (IVC) treated by a portal decompressive procedure that bypassed the obstructed IVC; and the third group, who had advanced cirrhosis and hepatic decompensation and were referred too late for treatment by portal decompression, required orthotopic liver transplantation"
Order ALL the reference details at left...

Related Drugs and Biologics

1. Neomycin
2. Aldosterone
3. Vasoconstrictor Agents
4. Tacrolimus (Prograf)
5. Interleukin-1 (Interleukin 1)
6. Ammonia
7. salicylhydroxamic acid (SHAM)
8. Cholesterol
9. ammonium acetate
10. Glucose (Dextrose)

Related Therapies and Procedures

1. Ligation
2. Sclerotherapy
3. Transplants (Transplant)
4. Surgical Portasystemic Shunt (Portosystemic Shunt)
5. Splenectomy

Best Treatments:
Research Summary Report
on Hemorrhage

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.
  • Free Updates for 1 Year
  • All 2881 Outcomes
  • Top 200 Key Drugs and Biologics
  • Top 50 Key Therapies and Procedures
  • Detailed History Charts
  • Full Research Reference Details
  • Sample PDF Report on Psoriasis >>
Price:$24.00 & Delivery via PDF download
updates for 1 year
Research Interface

 

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.
  • Unlimited Disease, Drug and Therapy Search
  • 2 clicks from Disease to Drug to Evidence
  • Trial References
  • All the Positive Outcomes
  • Detailed Relationship Timeline Charts
  • Full Article Reference Details
  • Includes Mobile Interface Subscription
  • One-click to FDA Products/Patents
  • Request Institution License Details >>
Price:$490.00 access via web interface
1 year subscription
Proceed to Checkout >>
Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.
  • Access from any web enabled PDA or Phone
  • Trial references
  • All the Positive Outcomes
  • Drug and Therapy searches
  • Full Article Reference Details
  • Try Mobile Interface >>
Price:$45.00 access via "curehunter.com/m"
1 year subscription
Proceed to Checkout >>